Alicja Kalinowska-Lyszczarz

Przybyszewskiego Str. 49
Poznan, WP 60355, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

The impact of white matter brain lesions on processing speed deficits in systemic lupus erythematosus patients.

The impact of white matter brain lesions on processing speed deficits in systemic lupus erythematosus patients.

Journal: Lupus

Published: February 10, 2025

Clinical, immunological and neuroimaging spectrum of CNS lupus: can we reliably differentiate it from MS?

Clinical, immunological and neuroimaging spectrum of CNS lupus: can we reliably differentiate it from MS?

Journal: Neurologia i neurochirurgia polska

Published: November 13, 2024

Infrared spectral profiling of demyelinating activity in multiple sclerosis brain tissue.

Infrared spectral profiling of demyelinating activity in multiple sclerosis brain tissue.

Journal: Acta neuropathologica communications

Published: July 10, 2024

Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions.

Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions.

Journal: Frontiers in molecular neuroscience

Published: June 12, 2024

Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study.

Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study.

Journal: Neurologia i neurochirurgia polska

Published: October 04, 2023

New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis.

New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis.

Journal: Acta neuropathologica

Published: September 05, 2023

The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician's review.

The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician's review.

Journal: Frontiers in neurology

Published: May 14, 2023

Prevalence and prognostic value of prodromal symptoms in relapsing-remitting multiple sclerosis.

Prevalence and prognostic value of prodromal symptoms in relapsing-remitting multiple sclerosis.

Journal: Neurologia i neurochirurgia polska

Published: February 10, 2023

Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians.

Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians.

Journal: Neurologia i neurochirurgia polska

Published: December 21, 2022

Long-term clinical, imaging and cognitive outcomes association with MS immunopathology.

Long-term clinical, imaging and cognitive outcomes association with MS immunopathology.

Journal: Annals of clinical and translational neurology

Published: December 03, 2022

ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis.

ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: November 28, 2022

Multiple sclerosis and related disorders: where do we stand in 2022?

Multiple sclerosis and related disorders: where do we stand in 2022?

Journal: Neurologia i neurochirurgia polska

Published: June 22, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026